Ingalls & Snyder LLC’s Idexx Laboratories IDXX Stock Holding History

Ingalls & Snyder LLC’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Hold	435	–	–	0.01%	414
2026 Q1	$244K	Hold	435	–	–	0.01%	394
2025 Q4	$294K	Hold	435	–	–	0.01%	373
2025 Q3	$278K	Hold	435	–	–	0.01%	398
2025 Q2	$233K	Sell	435 -100	-19%	-$47.8K	0.01%	406
2025 Q1	$225K	Buy	535 +5	+0.9%	+$2.17K	0.01%	397
2024 Q4	$219K	Hold	530	–	–	0.01%	395
2024 Q3	$268K	Hold	530	–	–	0.01%	382
2024 Q2	$258K	Hold	530	–	–	0.01%	361
2024 Q1	$286K	Hold	530	–	–	0.01%	355
2023 Q4	$294K	Hold	530	–	–	0.01%	352
2023 Q3	$232K	Hold	530	–	–	0.01%	381
2023 Q2	$266K	Buy	530 +50	+10%	+$24K	0.01%	368
2023 Q1	$240K	Buy	+480	New	+$230K	0.01%	375
2022 Q2	–	Sell	-508	Closed	-$278K	–	458
2022 Q1	$278K	Hold	508	–	–	0.01%	386
2021 Q4	$334K	Hold	508	–	–	0.02%	363
2021 Q3	$316K	Hold	508	–	–	0.01%	375
2021 Q2	$321K	Hold	508	–	–	0.01%	375
2021 Q1	$249K	Buy	508 +2	+0.4%	+$1K	0.01%	389
2020 Q4	$253K	Buy	+506	New	+$226K	0.01%	373
2020 Q3	–	Sell	-806	Closed	-$266K	–	406
2020 Q2	$266K	Buy	+806	New	+$233K	0.02%	332
2020 Q1	–	Sell	-841	Closed	-$220K	–	422
2019 Q4	$220K	Sell	841 -2	-0.2%	-$527	0.01%	362
2019 Q3	$229K	Buy	+843	New	+$235K	0.01%	381

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ingalls & Snyder LLC's IDXX Position: Q2 2026 in Review

Ingalls & Snyder LLC held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 435 shares worth $229K. The position accounts for 0.01% of the portfolio, ranked #414.

Ingalls & Snyder LLC first reported a position in IDXX in Q3 2019 and has held it in 23 quarters since. The position peaked at $334K in Q4 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Ingalls & Snyder LLC held 435 shares of Idexx Laboratories worth $229K as of Q2 2026.
Ingalls & Snyder LLC left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.01% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #414 holding.
Ingalls & Snyder LLC first reported a position in Idexx Laboratories in Q3 2019 and has held it in 23 quarters since.
Ingalls & Snyder LLC's Idexx Laboratories position peaked at $334K in Q4 2021.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.